Home › Companies › Artificial Intelligence (AI), Biotechnology, Health Care, Therapeutics › Artivila Therapeutics
Artivila Therapeutics
Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine.
Artivila Therapeutics is active in the artificial intelligence (ai), biotechnology, health care, therapeutics space based in Asia-Pacific (APAC), founded in 2018.
Its activity falls under artificial intelligence (ai), biotechnology, health care, therapeutics; the profile below is assembled from public directory data.
Asia-Pacific (APAC) is where the company is located.
Its current recorded stage is Seed.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $250M.
| Sector | Artificial Intelligence (AI), Biotechnology, Health Care, Therapeutics |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Country | CN |
| Founded | 2018 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $250,000,000 |
Website: www.artivila.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account